Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa-Reference-Cited by-同舟云学术

Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa

Published:2020-01 Issue:4 Volume:38 Page:897-906
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Otieno Lucas^ORCID,Guerra Mendoza Yolanda,Adjei Samuel,Agbenyega Tsiri,Agnandji Selidji Todagbe,Aide Pedro,Akoo Pauline,Ansong Daniel,Asante Kwaku Poku,Berkley James A^ORCID,Gesase Samwel,Hamel Mary J.,Hoffman Irving,Kaali Seyram^ORCID,Kamthunzi Portia,Kariuki Simon,Kremsner Peter,Lanaspa Miguel,Lell Bertrand,Lievens Marc,Lusingu John,Malabeja Anangisye,Masoud Nahya Salim,Mtoro Ali Takadir,Njuguna Patricia,Ofori-Anyinam Opokua,Otieno Godfrey Allan,Otieno Walter,Owusu-Agyei Seth,Schuerman Lode,Sorgho Hermann^ORCID,Tanner Marcel,Tinto Halidou,Valea Innocent,Vandoolaeghe Pascale,Sacarlal Jahit,Oneko Martina

Funder

GlaxoSmithKline Biologicals SA

PATH Malaria Vaccine Initiative

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference38 articles.

1. World Health Organization. World Malaria Report 2018. Geneva: World Health Organization, https://www.who.int/malaria/publications/world-malaria-report-2018/report/en/; 2018 [accessed 1 April 2019].

2. Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS data 2018, http://www.unaids.org/sites/default/files/media_asset/unaids-data-2018_en.pdf; 2018 [accessed 1 April 2019].

3. Malaria and HIV coinfection in sub-Saharan Africa: prevalence, impact, and treatment strategies;Kwenti;Res Rep Trop Med,2018

4. The effect of malaria and HIV co-infection on anemia: a meta-analysis;Naing;Medicine (Baltimore),2016

5. Safety and efficacy of the RTS, S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial;Asante;Lancet Infect Dis,2011

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Policy uptake and implementation of the RTS,S/AS01 malaria vaccine in sub-Saharan African countries: status 2 years following the WHO recommendation;BMJ Global Health;2024-04

2. Malaria vaccine efficacy, safety, and community perception in Africa: a scoping review of recent empirical studies;Infection;2024-03-05

3. Frequency of serious adverse events and death in 5-17 months children receiving RTS,S/AS01E vaccine - a systematic review and meta-analysis of RCTs.;2024-03-04

4. Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adults;Journal of Clinical Investigation;2024-01-09

5. Systematic Review of Safety of RTS,S with AS01 and AS02 Adjuvant Systems Using Data from Randomized Controlled Trials in Infants, Children, and Adults;Clinical Pharmacology: Advances and Applications;2023-03